Camilla Perucchini: I have officially graduated with a Master of Science in Biotechnology curriculum
Camilla Perucchini, Clinical Study Coordinator at IFO – Istituto Nazionale Tumori Regina Elena – Istituto Dermatologico San Gallicano, shared on LinkedIn:
“I’m thrilled to share that I have officially graduated with a Master of Science in Biotechnology curriculum ‘Clinical Research’.
For my thesis, I had the privilege of exploring advancements in the oncology field with the research titled:
‘Nivolumab plus Ipilimumab versus Platinum-based Chemotherapy plus Nivolumab in Chemo-naive Patients with Recurrent or Metastatic Squamous Cell Lung Carcinoma.’
This work was conducted during an enriching internship at the IFO – Istituto Nazionale Tumori Regina Elena – Istituto Dermatologico San Gallicano , where I gained invaluable hands-on experience and deep insights into immunotherapy and its transformative potential for cancer treatment.
This milestone represents not just the culmination of years of hard work and learning but also the beginning of my commitment to contributing to impactful scientific advancements in biotechnology and oncology.
I’m deeply grateful to my mentors, and everyone who supported me throughout this journey. Looking forward to exploring new opportunities and collaborations in this dynamic and ever-evolving field!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023